These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18371)

  • 1. Nucleolar and functional characterization of lymphocytes following cyclophosphamide treatment.
    Dráber P; Nouza K
    Folia Biol (Praha); 1977; 23(3):158-69. PubMed ID: 18371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of thymus and peripheral lymphocyte populations characterized by the dominant nucleolar type.
    Dráber P; Nouza K
    Folia Biol (Praha); 1975; 21(6):387-99. PubMed ID: 1204886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation and suppression of graft-vs-host reactions by cyclophosphamide.
    Wander RH; Hilgard HR
    J Immunol; 1981 Mar; 126(3):901-4. PubMed ID: 7462635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymus dependence of lymphocyte trapping.
    Zatz MM; Gershon RK
    J Immunol; 1974 Jan; 112(1):101-6. PubMed ID: 4149589
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of cyclophosphamide on lymph node and peripheral blood lymphocytes in mice.
    Mackiewicz U; Brelińska-Peczalska R; Konys J
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):375-80. PubMed ID: 749786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of cyclophosphamide-sensitive T cells in graft-vs-host reactions.
    Schwartz A; Orbach-Arbouys S; Gershon RK
    J Immunol; 1976 Sep; 117(3):871-5. PubMed ID: 8571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of recovery from the effects of heterologous anti-lymphocyte serum. II. Recovery of the cells involved in antibody production.
    Jeejeebhoy HF; Singla O
    Immunology; 1972 May; 22(5):801-12. PubMed ID: 5063185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
    Sihvola M; Hurme M
    J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of cyclophosphamide on antibody formation in the mouse.
    Willers JM; Sluis E
    Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The graft-versus-host reaction and immune function. IV. B cell functional defect associated with a depletion of splenic colony-forming units in marrow of graft-versus-host-reactive mice.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):242-7. PubMed ID: 3511585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antilymphocyte serum on the thymus.
    Levey RH; Taub R
    Transplant Proc; 1969 Mar; 1(1):424-8. PubMed ID: 4944253
    [No Abstract]   [Full Text] [Related]  

  • 12. The circulating life span, immunocompetence and 3H-uridine uptake of small lymphocytes from thymus-grafted, neonatally thymectomized rats.
    Willis JI; Schwarz MR
    J Immunol; 1975 Sep; 115(3):734-8. PubMed ID: 125302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of thymus- and bone marrow-derived lymphocytes in rats by means of 3H-uridine incorporation.
    Klobusická M; Babusíková O; Koníková E; Novotná L
    Neoplasma; 1975; 22(6):631-8. PubMed ID: 1082556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interferonogenic agent tilorone as a modulator of GvH reaction in mice.
    Zschiesche W; Slavina E; Leipunskaya I
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):725-30. PubMed ID: 23088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete sequential regeneration of graft-vs.-host-induced severely dysplastic thymuses. Implications for the pathogenesis of chronic graft-vs.-host disease.
    Ghayur T; Seemayer TA; Xenocostas A; Lapp WS
    Am J Pathol; 1988 Oct; 133(1):39-46. PubMed ID: 3263049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the biological activity of thymus gland extracts (TFX). II. Effect of TFX on the blood and lymphatic organ picture of thymectomized mice in the post-neonatal period].
    Jaszcz W; Rzepecki W; Wojciechowski Z; Piotrowska K
    Patol Pol; 1980; 31(2):273-85. PubMed ID: 7422389
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and pathologic characteristics of graft-versus-host disease produced in cyclophosphamide-treated adult mice.
    Sandberg JS; Owens AH; Santos GW
    J Natl Cancer Inst; 1971 Jan; 46(1):151-60. PubMed ID: 4395991
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cyclophosphamide-induced elimination of lymphocytes from the spleen and lymph node on immune response in mice.
    Konys J; Mackiewicz U; Drygas J
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):783-8. PubMed ID: 7349098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood lymphocyte nucleoli of rats with Yoshida ascitic sarcoma and the effect of cyclophosphamide.
    Matĕjková E
    Folia Biol (Praha); 1975; 21(5):349-53. PubMed ID: 1201807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life span of small lymphocytes in the thymolymphatic tissues of normal and thymus-deprived BALB/C mice.
    Röpke C; Everett NB
    Anat Rec; 1975 Sep; 183(1):83-94. PubMed ID: 1080971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.